Pulmonary function tests in extremely low gestational age infants at one year of age.

bronchopulmonary dysplasia extremely preterm infants obstructive lung disease raised volume rapid thoracic compression technique respiratory outcomes

Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
02 2022
Historique:
revised: 03 11 2021
received: 02 08 2021
accepted: 06 11 2021
pubmed: 16 11 2021
medline: 26 3 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

Identifying neonatal and post-discharge exposures among extremely low gestational age newborns (ELGANs) that drive increased pulmonary morbidity and abnormal lung function at 1 year of age proves challenging. The NIH-sponsored Prematurity and Respiratory Outcomes Program (PROP), evaluated infant pulmonary function tests (iPFTs) at 1 year corrected age to determine which demographic and clinical factors are associated with abnormal lung function. iPFTs were performed on a PROP subcohort of 135 participants following Institutional Review Board (IRB)-approved written consent. Demographic data, Neonatal Intensive Care Unit (NICU) clinical care, and post-NICU exposures were analyzed for association with iPFTs. A significant decrease in forced expiratory volume at 0.5 s (FEV Neonatal demographic factors, respiratory support in the NICU, and a history of greater post-NICU medical utilization for respiratory disease had the strongest association with lower lung function at 1 year in ELGANs.

Identifiants

pubmed: 34779149
doi: 10.1002/ppul.25757
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-447

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL105702
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL101813
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL101798
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL101794
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL101456
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL101800
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL101465
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Keller RL, Feng R, DeMauro SB, et al. Prematurity, respiratory outcomes p. bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study. J Pediatr. 2017;187:89-97.
Bhandari A, McGrath-Morrow S. Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol. 2013;37:132-137.
Islam JY, Keller RL, Aschner JL, Hartert TV, Moore PE. Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;192:134-156.
Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L. Lung consequences in adults born prematurely. Thorax. 2015;70:574-580.
Stevens TP, Dylag A, Panthagani I, Pryhuber G, Halterman J. Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol. 2010;45:371-379.
Hoo AF, Gupta A, Lum S, et al. Impact of ethnicity and extreme prematurity on infant pulmonary function. Pediatr Pulmonol. 2014;49:679-687.
Robin B, Kim YJ, Huth J, et al. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37:236-242.
Sanchez-Solis M, Garcia-Marcos L, Bosch-Gimenez V, Perez-Fernandez V, Pastor-Vivero MD, Mondejar-Lopez P. Lung function among infants born preterm, with or without bronchopulmonary dysplasia. Pediatr Pulmonol. 2012;47:674-681.
Thunqvist P, Gustafsson P, Norman M, Wickman M, Hallberg J. Lung function at 6 and 18 months after preterm birth in relation to severity of bronchopulmonary dysplasia. Pediatr Pulmonol. 2015;50:978-986.
Martinez FD. Early-life origins of chronic obstructive pulmonary disease. N Engl J Med. 2016;375:871-878.
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946-1955.
Pryhuber GS, Maitre NL, Ballard RA, et al. Prematurity, respiratory outcomes program I. Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States. BMC Pediatr. 2015;15:37.
Ren CL, Feng R, Davis SD, et al. Tidal breathing measurements at discharge and clinical outcomes in extremely low gestational age neonates. Ann Am Thorac Soc. 2018;15:1311-1319.
Poindexter BB, Feng R, Schmidt B, et al. Prematurity, respiratory outcomes P. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12:1822-1830.
Davis SD, Rosenfeld M, Kerby GS, et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med. 2010;182:1387-1397.
Nguyen TT, Hoo AF, Lum S, Wade A, Thia LP, Stocks J. New reference equations to improve interpretation of infant lung function. Pediatr Pulmonol. 2013;48:370-380.
Lum S, Bountziouka V, Wade A, et al. New reference ranges for interpreting forced expiratory manoeuvres in infants and implications for clinical interpretation: a multicentre collaboration. Thorax. 2016;71:276-283.
Lu Z, Foong RE, Kowalik K, et al. Reference equations for the interpretation of forced expiratory and plethysmographic measurements in infants. Pediatr Pulmonol. 2018;53:907-916.
Goldstein AB, Castile RG, Davis SD, et al. Bronchodilator responsiveness in normal infants and young children. Am J Respir Crit Care Med. 2001;164:447-454.
Carlo WA, Finer NN, Walsh MC, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362:1959-1969.
Groll A, Tutz G. Variable selection for generalized linear mixed models by L 1-penalized estimation Stat Comput 2014;24:137-154.
Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Stat Methodol Ser B. 1996;58:267-288.
Wooldridge JM. Inverse probability weighted estimation for general missing data problems. J Econom. 2007;141:1281-1301.
Filbrun AG, Popova AP, Linn MJ, McIntosh NA, Hershenson MB. Longitudinal measures of lung function in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2011;46:369-375.
Shepherd EG, Clouse BJ, Hasenstab KA, et al. Infant pulmonary function testing and phenotypes in severe bronchopulmonary dysplasia. Pediatrics. 2018;141:141.
Friedrich L, Stein RT, Pitrez PM, Corso AL, Jones MH. Reduced lung function in healthy preterm infants in the first months of life. Am J Respir Crit Care Med. 2006;173:442-447.
Ryan RM, Feng R, Bazacliu C, et al. Prematurity, respiratory outcome program I. black race is associated with a lower risk of bronchopulmonary dysplasia. J Pediatr. 2019;207:130-135.
Shanmugam S, Nathan AM, Zaki R, et al. Parents are poor at labelling wheeze in children: a cross-sectional study. BMC Pediatr. 2016;16:80.
Mellis C. Respiratory noises: how useful are they clinically? Pediatr Clin North Am. 2009;56:1-17ix.
Greenough A, Limb E, Marston L, Marlow N, Calvert S, Peacock J. Risk factors for respiratory morbidity in infancy after very premature birth. Arch Dis Child Fetal Neonatal Ed. 2005;90:F320-F323.
Pramana IA, Latzin P, Schlapbach LJ, et al. Respiratory symptoms in preterm infants: burden of disease in the first year of life. Eur J Med Res. 2011;16:223-230.
Jadcherla SR, Hasenstab KA, Shaker R, Castile RG. Mechanisms of cough provocation and cough resolution in neonates with bronchopulmonary dysplasia. Pediatr Res. 2015;78:462-469.
Sanchez-Solis M, Perez-Fernandez V, Bosch-Gimenez V, Quesada JJ, Garcia-Marcos L. Lung function gain in preterm infants with and without bronchopulmonary dysplasia. Pediatr Pulmonol. 2016;51:936-942.
Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018;197:300-308.
Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532.
Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. an evidence-based approach. Am J Respir Crit Care Med. 2019;200:751-759.
McDowell KM, Jobe AH, Fenchel M, et al. Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants. Ann Am Thorac Soc. 2016;13:867-876.

Auteurs

Judith A Voynow (JA)

Division of Pediatric Pulmonology, Children's Hospital of Richmond at VCU, Richmond, Virginia, USA.

Rui Feng (R)

Department of Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Clement L Ren (CL)

Division of Pediatric Pulmonology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Division of Pediatric Pulmonology, University of Rochester, Rochester, New York, USA.
Division of Pediatric Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children, Indiana University, Indianapolis, Indiana, USA.

Andrew M Dylag (AM)

Division of Neonatology, University of Rochester, Rochester, New York, USA.

James S Kemp (JS)

Division of Pediatric Pulmonology, Washington University Medical Center, St. Louis, Missouri, USA.

Karen McDowell (K)

Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Jack Sharp (J)

Division of Pediatric Pulmonology, Duke University Medical Center, Durham, North Carolina, USA.
Division of Pediatric Pulmonology, Texas Children's Hospital, Woodlands, Texas, USA.

Paul E Moore (PE)

Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Eric Eichenwald (E)

Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Division of Neonatology, University of Texas Health Science Center- Houston, Houston, Texas, USA.

Howard Panitch (H)

Division of Pediatric Pulmonology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Charles Clem (C)

Division of Pediatric Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children, Indiana University, Indianapolis, Indiana, USA.

Robin Johnson (R)

Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Stephanie D Davis (SD)

Division of Pediatric Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children, Indiana University, Indianapolis, Indiana, USA.
Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH